151 related articles for article (PubMed ID: 26584327)
1. SHORT-TERM FLUCTUATION OF MACULAR EDEMA IN A PATIENT DIAGNOSED EARLY WITH IDIOPATHIC MACULAR TELANGIECTASIA TYPE 1: FOLLOW-UP WITH SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
Tsaousis KT; Empeslidis T
Retin Cases Brief Rep; 2016; 10(3):263-6. PubMed ID: 26584327
[TBL] [Abstract][Full Text] [Related]
2. Optical coherence tomography angiography of macular telangiectasia type 1: Comparison with mild diabetic macular edema.
Mao L; Weng SS; Gong YY; Yu SQ
Lasers Surg Med; 2017 Mar; 49(3):225-232. PubMed ID: 28168812
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
4. Phakic cystoid macular edema secondary to idiopathic macular telangiectasia type 1 responsive to topical anti-inflammatory agents.
Dunn EN; Gregori NZ; Goldhardt R
Semin Ophthalmol; 2013 Mar; 28(2):84-7. PubMed ID: 23448562
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.
Roller AB; Folk JC; Patel NM; Boldt HC; Russell SR; Abramoff MD; Mahajan VB
Retina; 2011 Oct; 31(9):1848-55. PubMed ID: 21610563
[TBL] [Abstract][Full Text] [Related]
6. Spectral-domain optical coherence tomography in Irvine-Gass syndrome.
Minnella AM; Savastano MC; Zinzanella G; Mazzone G; Federici M; Gari M; Falsini B; Balestrazzi E
Retina; 2012 Mar; 32(3):581-7. PubMed ID: 21963486
[TBL] [Abstract][Full Text] [Related]
7. Spectral domain optical coherence tomography predictors of visual outcome in diabetic cystoid macular edema after bevacizumab injection.
Al Faran A; Mousa A; Al Shamsi H; Al Gaeed A; Ghazi NG
Retina; 2014 Jun; 34(6):1208-15. PubMed ID: 24368308
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of macular edema in retinal vein occlusion using optical coherence tomography and its visual prognosis].
Zhang HR; Wang X; Lu XR; Yang YF; Liu F
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):910-6. PubMed ID: 16271177
[TBL] [Abstract][Full Text] [Related]
9. Unveiling idiopathic macular telangiectasia: clinical applications of optical coherence tomography angiography.
Gonzalez MA; Shechtman D; Haynie JM; Semes L
Eur J Ophthalmol; 2017 Jun; 27(4):e129-e133. PubMed ID: 28525681
[TBL] [Abstract][Full Text] [Related]
10. Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.
Wu L
Indian J Ophthalmol; 2015 May; 63(5):394-8. PubMed ID: 26139799
[TBL] [Abstract][Full Text] [Related]
11. "En face" optical coherence tomography imaging in type 2 idiopathic macular telangiectasia.
Wolff B; Basdekidou C; Vasseur V; Sahel JA; Gaudric A; Mauget-Faÿsse M
Retina; 2014 Oct; 34(10):2072-8. PubMed ID: 25255245
[TBL] [Abstract][Full Text] [Related]
12. MULTIMODAL IMAGING OF UNILATERAL IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2: A FIVE-YEAR STUDY.
Manayath GJ; Verghese S; Narendran V
Retin Cases Brief Rep; 2024 Mar; 18(2):230-235. PubMed ID: 36026689
[TBL] [Abstract][Full Text] [Related]
13. The pearl necklace sign: a novel spectral domain optical coherence tomography finding in exudative macular disease.
Gelman SK; Freund KB; Shah VP; Sarraf D
Retina; 2014 Oct; 34(10):2088-95. PubMed ID: 25020214
[TBL] [Abstract][Full Text] [Related]
14. Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2.
Mathew R; Sivaprasad S; Florea D; Leung I; Sallo F; Clemons T; Bird AC; Peto T
Ophthalmologica; 2013; 230(3):144-50. PubMed ID: 23989133
[TBL] [Abstract][Full Text] [Related]
15. Non-full-thickness macular holes reassessed with spectral domain optical coherence tomography.
Michalewska Z; Michalewski J; Odrobina D; Nawrocki J
Retina; 2012 May; 32(5):922-9. PubMed ID: 21909051
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study-Report No. 1.
Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
Sci Rep; 2020 Oct; 10(1):16594. PubMed ID: 33024250
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of macular edema of different pathophysiologic origins by spectral domain optical coherence tomography.
Munk MR; Sacu S; Huf W; Sulzbacher F; Mittermüller TJ; Eibenberger K; Rezar S; Bolz M; Kiss CG; Simader C; Schmidt-Erfurth U
Retina; 2014 Nov; 34(11):2218-32. PubMed ID: 25011028
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mathematical morphological descriptors of hyporeflective cavities in optical coherence tomography of patients with macular telangiectasia compared to patients with diabetic maculopathy.
Aslam T; Tan SZ; D'Souza Y; Balaskas K; Mahmood S
Acta Ophthalmol; 2014 Nov; 92(7):e580-1. PubMed ID: 24667012
[No Abstract] [Full Text] [Related]
19. Type 2 idiopathic macular telangiectasia.
Shukla D; Gupta SR; Neelakantan N; Tiwari S; Gupta S; Patwardhan AR; Soubhya TB
Retina; 2012 Feb; 32(2):265-74. PubMed ID: 21968508
[TBL] [Abstract][Full Text] [Related]
20. CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Zeimer MB; Sallo FB; Spital G; Heimes B; Lommatzsch A; Pauleikhoff D
Retina; 2016 Mar; 36(3):535-44. PubMed ID: 26398690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
